Neutrophil gelatinase-associated lipocalin (NGAL), a member of the lipocalin superfamily that is expressed by neutrophils and various epithelial cells [5], is one of the most frequently investigated and a rapidly emerging biomarker for early prediction of different clinical settings of AKI [6]. The gene discussed is LCN2; the disease is acute kidney injury.